MELANOMA ANTIGEN PREFERENTIALLY EXPRESSED IN TUMORS
UNII S3GM5F8G7C

Substance Identification & Data

This profile provides standardized clinical and technical data for Melanoma Antigen Preferentially Expressed In Tumors, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S3GM5F8G7C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S3GM5F8G7C

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MELANOMA ANTIGEN PREFERENTIALLY EXPRESSED IN TUMORS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

S3GM5F8G7C

The specific atomic composition represented as a molecular structure string.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Melanoma Antigen Preferentially Expressed In Tumors. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.